EMD 1201081
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EMD 1201081, covering 2014-06-17 to 2014-07-29. Get the full timeline:
Most recent: Clinical Trial Update: EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]